Welcome to the May 25th 2007 edition of Carnival of Biotechnology. Finance and business development The big news on the web is Google’s investment in 23andMe, described here by the California Biotech Law Blog. International biotech Business Week has an article on The Rush To Test Drugs In China. This is a story with a […]
I’ve been tracking the global spread of biotechnology for quite a while now. I’m fascinated with why biotechnology has taken root so strongly in the United States while many other countries are struggling to develop critical mass. This is the topic of a paper I’ve recently co-submitted in response to a request from the American […]
If, like me, you miss the late Acumen Journal, you’ll be glad to hear that a very similar journal has launched. The Journal of Life Sciences brands itself “Where science and society meet.” A copy appeared in the mail a few weeks ago, and I’ve been meaning to post a blog about it. Now that […]
I’ll be giving a talk on career development in biotechnology at UNC-Chapel Hill on Wednesday May 16th at 4pm in the Bioinformatics Building (ground floor auditorium), to be followed by a social/networking session at Top of the Hill (local brewery) at 5:30. My talk will open with my meandering career path, (hopefully) provide some guidance […]
What does Greenpeace oppose more: Patents, or genetic modification? This question has been answered in a recent patent case where the European Patent Office (EPO) rejected a Monsanto patent for a technique for genetic modification of plants. The patent, which was due to expire in 2008, describes a method to use a ‘particle gun’ to […]
My article on the top five biotechnology blogs is up at Biotech360. Hope I don’t get too much hatemail over the blogs I didn’t mention; with a limit of five blogs I tried to identify one representative blog for policy, research, IP, marketing, and general innovation.
India’s biotechnology industry has the potential to become a major driver of the country’s economy, but is challenged by one vital omission: patent protection. While current patent laws support a strong Indian generic industry, they also impede foreign investment. Without foreign investment India loses trading opportunities, and without a capacity to produce branded drugs India […]
Courtesy of DrugPatentWatch.com: Drug Patent Expirations in May 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration DIPROLENE Schering betamethasone dipropionate 4,775,529 MAY 21,2007 HABITROL Novartis nicotine 5,834,011 MAY 01,2007 OMNISCAN Ge Healthcare gadodiamide 4,687,659 MAY 04,2007 PATANOL Alcon olopatadine hydrochloride 4,923,892 MAY 08,2007 RANEXA Cv Therap […]